337 related articles for article (PubMed ID: 26384361)
1. Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.
Bird SR; Goebel C; Burke LM; Greaves RF
Ann Clin Biochem; 2016 Mar; 53(Pt 2):196-221. PubMed ID: 26384361
[TBL] [Abstract][Full Text] [Related]
2. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
3. Doping in sport: effects, harm and misconceptions.
Birzniece V
Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
[TBL] [Abstract][Full Text] [Related]
4. [The use of drugs to improve athletic performance].
Kuipers H; Hartgens F
Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
[TBL] [Abstract][Full Text] [Related]
5. [Use of testosterone and anabolic androgenic steroids in sport].
Medraś M; Jóźków P
Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
[TBL] [Abstract][Full Text] [Related]
6. Detection of doping in sport: detecting anabolic-androgenic steroids in human fingernail clippings.
Brown HG; Perrett D
Med Leg J; 2011; 79(Pt 2):67-9. PubMed ID: 21673061
[No Abstract] [Full Text] [Related]
7. Use of doping agents, particularly anabolic steroids, in sports and society.
Sjöqvist F; Garle M; Rane A
Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
[TBL] [Abstract][Full Text] [Related]
8. Anabolic steroids in sport: biochemical, clinical and analytical perspectives.
Kicman AT; Gower DB
Ann Clin Biochem; 2003 Jul; 40(Pt 4):321-56. PubMed ID: 12880534
[TBL] [Abstract][Full Text] [Related]
9. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
[TBL] [Abstract][Full Text] [Related]
10. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
11. Recruitment to doping and help-seeking behavior of eight female AAS users.
Börjesson A; Gårevik N; Dahl ML; Rane A; Ekström L
Subst Abuse Treat Prev Policy; 2016 Mar; 11():11. PubMed ID: 26945991
[TBL] [Abstract][Full Text] [Related]
12. A Netnography and a Survey on Doping Use among Competitive Doping-untested Strength-sport Athletes.
Jokipalo I; Khudayarov A
Int J Sports Med; 2021 Jun; 42(7):645-650. PubMed ID: 33506442
[TBL] [Abstract][Full Text] [Related]
13. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
Anawalt BD
Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
[TBL] [Abstract][Full Text] [Related]
14. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
Tentori L; Graziani G
Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
[TBL] [Abstract][Full Text] [Related]
15. Anabolic steroid use: patterns of use and detection of doping.
Graham MR; Davies B; Grace FM; Kicman A; Baker JS
Sports Med; 2008; 38(6):505-25. PubMed ID: 18489196
[TBL] [Abstract][Full Text] [Related]
16. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
[TBL] [Abstract][Full Text] [Related]
17. [Doping: effectiveness, consequences, prevention].
Guezennec CY
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
[TBL] [Abstract][Full Text] [Related]
19. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.
Santos MA; Oliveira CV; Silva AS
Subst Use Misuse; 2014 Jul; 49(9):1132-7. PubMed ID: 24832723
[TBL] [Abstract][Full Text] [Related]
20. Anabolic steroids in sport.
VanHelder WP; Kofman E; Tremblay MS
Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
